Skip to main content
OpenTrials
Completed

NCT Number: NCT05708742

Erector Spinae Plane Block and Ankle and Foot Surgery

Regional anesthesia is commonly used in orthopedic and surgical procedures in ankle and foot surgery to manage pain. The ultrasound-guided nerve block is a safe and effective regional anesthesia technique that provides effective pain management, decreasing opioid consumption.

Postoperative pain management may be challenging and requires a multimodal approach. Regional anesthesia techniques in the pediatric ankle and foot surgery population are frequently used in postoperative pain management due to ultrasonography's increased experience and accessibility.

Erector spinae plane block (ESP) is a relatively new regional anesthesia technique that provides analgesia covering spinal nerves' dorsal and ventral rami. There are few cases reports in the literature on the use of ESP block for lower limb surgery, for which it has a promising potential for future indication.

The erector spinae plane block is a safe and effective regional anesthesia technique, which has earned new indications perioperatively since its description.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Fayoum University hospital

El Fayoum Qesm, Faiyum Governorate, 63514, Egypt

About this study

This single-center study was a prospective randomized controlled trial, using parallel groups with a 1:1 allocation ratio. Eligible patients were identified by the surgeon and invited to participate in the study. If the patient wished to participate in the study, informed consent was obtained. The patient was informed of the study's nature, especially that the patient would be randomized to receive an ESPB or a sham block before the procedure. A computerized randomization program (permuted block randomization) was used to create the allocation before the beginning of the study. Research staff not involved in the recruitment process or the study's conduct randomized patients at the time of admission to the clinic. Randomization allocation was 1:1 between treatment and control groups. Apart from the anesthesiologists who performed the blocks, all patients, surgeons, and postoperative nurses remained blinded to randomization throughout the study period. The outcome parameters were recorded through a study nurse who was not involved in the patients' care.

All patients received standardized anesthesia, and all blocks were performed by 2 anesthesiologists who were trained in this technique. A large-bore intravenous (IV) line was placed, and patients received midazolam 1 to 2 mg IV for anxiolysis.

Anesthesia was induced with fentanyl 2 mcg.kg-1 and propofol 2 mg.kg-1 followed by atracurium 0.5 mg.kg-1 . After intubation, anesthesia was maintained with isoflurane (1 MAC) and atracurium 0.1mg.kg-1 as a maintenance dose every 30 min until the end of the procedure. After emerging from anesthesia, patients were transferred to the postanesthesia care unit (PACU) for a 2-h observation period. Patients were discharged from the PACU when they achieved a modified Aldrete score ≥ 9.10. Postoperative analgesia was provided in both groups immediately after surgery by PCA fentanyl pump, then oral acetaminophen 1 g four times a day. The criteria to stop the fentanyl titration protocol included satisfactory pain control, increased sedation (Ramsay sedation scale >2), decreased respiratory rate.

Statistical Analyses The sample size was estimated to achieve a power of 0.8 to detect a supposed medium effect size of 0.7 in between the two groups regarding total morphine consumption, with a 2-sided significance level of .05 and allocation ratio of 1. Thirty patients in each group were required. Allowing for a 10% loss, 34 patients were recruited in each group, for a total of 68 patients. The sample size was determined using G*Power software (version 3.1.9.7).

Descriptive statistics, including age, sex, body mass index, baseline pain scores, procedure type, traction time, and procedure time, were comparatively analyzed between the groups. Categorical data were compared with chi-squared and Fisher's exact tests as appropriate. Continuous data were compared with a 2-sided t test (for normally distributed data) and Wilcoxon rank-sum test (for non normally distributed data). For all analyses (primary and secondary measures), a P value of .05 was used to determine statistical significance. Statistical analyses were conducted using SPSS version 28 (Addinsoft, Paris, France).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 - 65 years, American Society of Anesthesiologists physical status classification Ι and ΙΙ; scheduled for ankle and foot surgery

Exclusion criteria

  • Major hepatic
  • severe renal impairment (creatinine > 3 or on dialysis);
  • severe cardiovascular disease (ejection fraction < 35%)
  • local infection at site of injection
  • Any contraindication for ESP
  • Known allergy to any drug used in the study

Treatment and study plan

Ultrasound

Device

A linear US transducer (Phillips-Saronno Italy) was placed vertically 3 cm lateral to the midline to visualize back muscles: the trapezius above, the rhomboid major in the middle, and the erector-spinae muscle on the bottom, as well as the TPs with shimmering pleura in between.

Other names: Linear transducer

Bupivacaine Hydrochloride

Drug

The ESP block group underwent US-guided ESP block at L4 vertebrae level with 20 ml of bupivacaine 0.25%.

Other names: Local anesthetic

Saline Solution

Drug

The control group underwent the same procedure but had a sham injection (20 ml of saline).

Other names: Saline isotonic 0.9%

needle

Device

A 22-gauge short bevel needle (Spinocan, B. Braun Melsungen AG, Germany) was inserted in the cranial-caudal direction towards the TP in-plane with the US transducer until the needle touched the TP crossing all three muscles.

Primary outcomes

  1. Visual Analog score

    Time frame: 8 hours after operation

    0 - 10 with 0: no pain and 10: worst pain

Secondary outcomes

  1. Total opioid consumption

    Time frame: First 24 hours postoperatively.

    in milligram

  2. time to first analgesic request

    Time frame: First 24 hours postoperatively.

    from end of operation to request of analgesia due to pain

  3. Incidence of nausea

    Time frame: First 24 hours postoperatively.

    yes or no

  4. Incidence of vomiting

    Time frame: First 24 hours postoperatively.

    yes or no

  5. patient satisfaction

    Time frame: First 24 hours postoperatively.

    1:3 with 1: very satisfied to 3: very unsatified

  6. Incidence of local anesthetic toxicity

    Time frame: First 24 hours postoperatively.

    yes or no

  7. Visual Analog score

    Time frame: 4 hours after operation

    0 - 10 with 0: no pain and 10: worst pain

  8. Visual Analog score

    Time frame: 12 hours after operation

    0 - 10 with 0: no pain and 10: worst pain

  9. Visual Analog score

    Time frame: 24 hours after operation

    0 - 10 with 0: no pain and 10: worst pain

Other outcomes

  1. Age

    Time frame: 1 hour preoperatively

    in years

  2. Height

    Time frame: 1 hour preoperatively

    in centimeter

  3. weight

    Time frame: 1 hour preoperatively

    in kilogram

  4. Sex

    Time frame: 1 hour postoperatively

    Female or Male

Sponsors and collaborators

Lead sponsor

Fayoum University Hospital

Other

Registry information

Official study title

The Analgesic Efficacy of Erector Spinae Plane Block in Ankle and Foot Surgery: A Randomized Controlled Study

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Feb 1, 2023
Registry last updated
Oct 4, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.